Enveric Biosciences Closes $3.1 Million Warrant Exercise Financing

Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuropla...

December 15, 2025 | Monday | News
Bavarian Nordic Announces Intention to Launch DKK 500 Million Share Buy-Back Program

Bavarian Nordic A/S  announced its intent to launch a one-time share buy-back program of up to DKK 500 million to be executed over the next 12 month...

December 03, 2025 | Wednesday | News
Merck Alerts Investors to Tutanota’s Unsolicited Mini-Tender Offer Priced Significantly Below Market

-Merck (NYSE: MRK), known as MSD outside the United States and Canada, has been notified that Tutanota LLC (Tutanota) has commenced an unsolicited &ldquo...

November 24, 2025 | Monday | News
Novartis Announces Major North Carolina Expansion as Part of $23B U.S. Infrastructure Investment

Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030 Enables manufacturing...

November 21, 2025 | Friday | News
Angelini Ventures Expands to Asia with Singapore Hub to Power Biotech and Healthtech Innovation

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelin...

November 14, 2025 | Friday | News
Merck CEO Belén Garijo Confirms Confident Momentum Across Healthcare And Life Science

  Net sales increase organically by +5.2% to € 5.3 billion; foreign exchange effects of –4.9%, portfolio effects of +0.7% EBI...

November 14, 2025 | Friday | Company results
Elephas Raises $40 Million in Series B-2 to Advance Commercialization of Live Tumor Profiling Platform

Reinvestment from existing backers underscores confidence in Elephas' predictive approach to improving immunotherapy treatment response rates Elephas B...

November 07, 2025 | Friday | News
Jupiter Neurosciences Secures Up to $20 Million in Flexible Financing from Yorkville Advisors to Advance Parkinson’s Trial and Nugevia™ Expansion

Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia™ product line growth Jupiter Neurosciences, Inc , a clinical...

October 28, 2025 | Tuesday | News
Minerva Neurosciences Secures up to $200 Million to Advance Roluperidone Through Confirmatory Phase 3 Trial and NDA Resubmission

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have ...

October 22, 2025 | Wednesday | News
Rani Therapeutics Enters $1 Billion Collaboration with Chugai for Oral Biologics Development

Rani will receive $10 million upfront payment and is eligible to receive up to $75 million in technology transfer and development milestones, up to $10...

October 20, 2025 | Monday | News
Santhera Secures CHF 20M in Growth Capital from Highbridge and R-Bridge

Santhera secures approximately CHF 20 million of additional funding from existing investors Highbridge and R-Bridge to accelerate global rollout Deman...

September 25, 2025 | Thursday | News
Yatiri Bio Secures Gates Foundation Grant to Advance Proteomics Interoperability for Global Health

Yatiri Bio Inc.  announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at imp...

September 23, 2025 | Tuesday | News
Cascade Bio Secures $6M to Power Cell-Free Biomanufacturing Revolution

Cascade Bio, an industrial biotech company enabling enzyme-based processes, has secured $6M to accelerate the shift from petrochemicals to biomanufacturi...

September 10, 2025 | Wednesday | News
IFF Expands LMR Naturals Site in Grasse with €10 Million Investment to Drive Next-Generation Natural Ingredient Innovation

-IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients and biosciences,  inaugurated its expanded LMR Naturals site in Grasse fo...

September 09, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close